Information Journal Paper
APA:
Copy. (2019). Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: A retrospective study. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 15(-), 911-919. SID. https://sid.ir/paper/757082/en
Vancouver:
Copy. Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: A retrospective study. THERAPEUTICS AND CLINICAL RISK MANAGEMENT[Internet]. 2019;15(-):911-919. Available from: https://sid.ir/paper/757082/en
IEEE:
Copy, “Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: A retrospective study,” THERAPEUTICS AND CLINICAL RISK MANAGEMENT, vol. 15, no. -, pp. 911–919, 2019, [Online]. Available: https://sid.ir/paper/757082/en